KXV01 TCR Lentinvivo is named as a drug or biological intervention in 3 clinical trials in our China trial register, 1 of which is recruiting. Lead sponsors include TCRx Therapeutics Co.Ltd (2) and The First Hospital of Jilin University (1). Registered phase: Phase 1. Conditions studied include Advanced Solid Tumors.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT07596693 | KXV01 Injection in Patients With Advanced Solid Tumor (Including Osteosarcoma and Sarcoma) Advanced Solid Tumors |
Phase 1 | Recruiting |
| NCT07207681 | Personalized KXV01 TCR Lentinvivo Injection as the Therapy for Advanced Solid Tumors (ClinicalTrials.gov ↗) Advanced Solid Tumors |
Phase 1 | Not yet open |
| NCT07275853 | Personalized KXV01 Lentinvivo (TCR) Injection as the Therapy for Advanced Solid Tumors (ClinicalTrials.gov ↗) Advanced Solid Tumors |
Phase 1 | Not yet open |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Advanced Solid Tumors | 3 |
| Lead sponsor | Trials |
|---|---|
| TCRx Therapeutics Co.Ltd | 2 |
| The First Hospital of Jilin University | 1 |
| Register | KXV01 TCR Lentinvivo trials |
|---|---|
| Clinical trials in China | 3 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how KXV01 TCR Lentinvivo works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists KXV01 TCR Lentinvivo (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.